Skip to main content
. 2022 Aug 5;12:13503. doi: 10.1038/s41598-022-17755-2

Table 1.

Patient characteristics.

Unique ID Group Age (year) Gender Nephrectomy type Creatinine Primary tumour status Tumour size (mm) Fuhrmann grade Leibovich Score 20031 Leibovich Score 20182 Time to metastasis (days) Pair ID
RCC01 Progressor 72 Female Radical 106 T1a 20 2 0 2 2680 5
RCC02 Progressor 72 Male Radical 109 T1b 50 2 2 5 2319 6
RCC03 Progressor 66 Male Radical 113 T1a 35 3 1 3 2632 3
RCC05 Progressor 83 Male Radical 81 T1b 50 2 2 5 109 7
RCC06 Progressor 67 Male Radical 176 T1b 48 2 2 5 1385 8
RCC08 Progressor 63 Male Radical 60 T1a 40 3 1 3 1994 2
RCC09 Progressor 51 Female Radical 58 T1a 38 3 2 5 1544 1
RCC11 Progressor 66 Male Partial 61 T1a 15 3 2 5 965 4
RCC04 Nonprogressor 63 Male Radical 82 T1b 50 2 2 5 6
RCC07 Nonprogressor 76 Male Radical 98 T1b 45 2 2 5 7
RCC10 Nonprogressor 78 Female Partial 64 T1a 20 2 0 2 5
RCC12 Nonprogressor 63 Male Radical 80 T1b 45 2 2 5 8
RCC13 Nonprogressor 34 Male Partial 73 T1a 23 3 1 3 1
RCC14 Nonprogressor 72 Male Partial 97 T1b 55 2 2 5 6
RCC15 Nonprogressor 75 Male Radical 73 T1b 45 2 2 5 7
RCC16 Nonprogressor 62 Male Radical 82 T1a 30 3 1 3 3
RCC17 Nonprogressor 54 Male Partial 68 T1a 35 3 1 3 2
RCC18 Nonprogressor 68 Female Partial 45 T1a 20 2 0 2 5
RCC19 Nonprogressor 68 Male Radical 68 T1b 45 2 2 5 8
RCC20 Nonprogressor 66 Male Radical 67 T1a 30 3 1 3 2
RCC21 Nonprogressor 57 Male Partial 73 T1a 30 3 1 3 3
RCC22 Nonprogressor 66 Male Partial 83 T1a 38 3 1 3 4
RCC23 Nonprogressor 74 Male Partial 81 T1a 16 3 1 3 4
RCC24 Nonprogressor 47 Female Partial 48 T1a 40 3 1 3 1

One NP patient (RCC19) developed a metastasis after 10 years of follow-up.